Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec;93(12):6803-6807.
doi: 10.1002/jmv.27220. Epub 2021 Jul 27.

Evaluation of a rapid antigen detection test (Panbio™ COVID-19 Ag Rapid Test Device) as a point-of-care diagnostic tool for COVID-19 in a pediatric emergency department

Silvia Carbonell-Sahuquillo  1 , María I Lázaro-Carreño  1   2 , Jorge Camacho  3 , Ana Barrés-Fernández  1 , Eliseo Albert  3 , Ignacio Torres  3 , José R Bretón-Martínez  1   2 , Cecilia Martínez-Costa  1   2 , David Navarro  3   4
Affiliations

Evaluation of a rapid antigen detection test (Panbio™ COVID-19 Ag Rapid Test Device) as a point-of-care diagnostic tool for COVID-19 in a pediatric emergency department

Silvia Carbonell-Sahuquillo et al. J Med Virol. 2021 Dec.

Abstract

We evaluated the Panbio™ COVID-19 Ag Rapid Test Device as a point-of-care diagnostic tool for COVID-19 in 357 patients at a pediatric emergency department. Thirty-four patients tested positive by reverse transcription polymerase chain reaction, of which 24 were positive by the antigen assay. The sensitivity and specificity of the assay were 70.5% and 100%, respectively.

Keywords: SARS-CoV-2 RNA viral load; clinical sensitivity; emergency department; field evaluation; pediatric patients; rapid antigen assay.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflict of interests.

References

    1. Overview of testing for SARS‐CoV‐2 (COVID‐19). Updated September 18, 2020. https://www.cdc.gov/coronavirus/2019-ncov/hcp/testing-overview.html
    1. SARS‐CoV‐2 diagnostic pipeline. Finddx.org. 2021. https://www.finddx.org/covid-19/pipeline
    1. Hayer J, Kasapic D, Zemmrich C. Real‐world clinical performance of commercial SARS‐CoV‐2 rapid antigen tests in suspected COVID‐19: a systematic meta‐analysis of available data as per November 20, 2020. Int J Infect Dis. 2021;108:592‐602. - PMC - PubMed
    1. Albert E, Torres I, Bueno F, et al. Field evaluation of a rapid antigen test (Panbio COVID‐19 Ag Rapid Test Device) for COVID‐19 diagnosis in primary healthcare centres. Clin Microbiol Infect. 2020;27(472):e7‐472. - PMC - PubMed
    1. Villaverde S, Domínguez‐Rodríguez S, Sabrido G, et al. Diagnostic accuracy of the Panbio SARS‐CoV‐2 antigen rapid test compared with RT‐PCR testing of nasopharyngeal samples in the pediatric population. J Pediatr. 2021;232:287‐289. - PMC - PubMed

Publication types

Substances